Defining the role of microRNAs in CD8 T cell exhaustion
定义 microRNA 在 CD8 T 细胞耗竭中的作用
基本信息
- 批准号:9012770
- 负责人:
- 金额:$ 24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-15 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptive TransferAntigensBiologyCD8B1 geneCellsChronicClinicalClinical TrialsCodeCommunicable DiseasesDataDevelopmentDiseaseEquilibriumFoundationsFunctional disorderFutureGene ExpressionGenesGenetic TranscriptionHIVHealthHepatitis BHepatitis CHumanImmuneImmune System DiseasesImmunityIndividualInfectionInflammationInflammatoryInvestigationLymphocytic choriomeningitis virusMalignant NeoplasmsMemoryMessenger RNAMicroRNAsMicroarray AnalysisMolecularMorbidity - disease rateMusPathway interactionsPatternProteinsRoleSourceT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTransgenic OrganismsUntranslated RNAVaccinesViralVirusVirus Diseasesantimicrobial drugbasecancer therapydifferential expressionexhaustexhaustioninsightmortalitynew therapeutic targetnoveloverexpressionprogenitorprogramsreceptorsuccesstranscription factor
项目摘要
DESCRIPTION (provided by applicant): Persistent viral infections, including HIV, hepatitis B and C are major causes of morbidity and mortality worldwide. Despite our successes with acute infections using anti-microbial agents and vaccines, persisting viral infections cause considerable disease. CD8 T cells responding to chronic viral infections become dysfunctional, a state termed "exhaustion". Transcriptional profiling of mRNA has revealed major insights into the biology of T cell exhaustion including the identification of key transcription factors, as wellas immunoregulatory pathways, such as PD-1 and LAG-3 that have major roles in controlling T cell exhaustion. These latter findings have led to highly promising clinical trials for treating chronic
infectious diseases and cancer. Despite these advances, the molecular mechanisms of CD8 T cell exhaustion remain incompletely defined. Specifically, our understanding of the gene expression program of T cell exhaustion has been limited so far to only protein-coding mRNA. In the past decade, non-coding RNAs and especially microRNAs (miRs) have been identified as crucial regulators of cell development, differentiation, and function. However, the role of miRs in
immunity to infection is only beginning to be revealed and specifically the role of miRs in regulating CD8 T cell exhaustion during chronic viral infection is unknown. Our preliminary data indicate that miR-155 and other miRs are associated with differences between memory and exhausted CD8 T cells, but precisely how these non-coding RNAs regulate T cell exhaustion is unclear. Thus, we hypothesize that specific miRs, including miR-155, regulate the differences in differentiation, function and transcription of protein coding genes between functional memory and exhausted CD8 T cells. To test this hypothesis we propose: Aim 1. To investigate the role of miR-155 in chronic viral infection. We will manipulate miR-155 expression to test how this miR regulates the development and/or persistence of exhausted CD8 T cells during chronic viral infection. Aim 2. To identify novel miRs regulating CD8 T cell exhaustion during chronic viral infections. We will test the role of novel differentially expressed miRs in regulating exhaustion v memory. Clinical approaches to modulate T cell exhaustion based on targeting PD-1 and other inhibitory receptors are highly promising for the treatment of cancer and chronic infections. However, with efficacy ranging from 10- 50%, other approaches and a deeper understanding of T cell exhaustion is clearly warranted. With clinical approaches to modulate miRs rapidly developing, the proposed studies will provide a foundation for future miR-based therapeutic advances in infection and cancer.
描述(由申请方提供):持续性病毒感染,包括HIV、B型和C型肝炎,是全球发病率和死亡率的主要原因。尽管我们使用抗微生物剂和疫苗在急性感染方面取得了成功,但持续的病毒感染会引起相当大的疾病。响应慢性病毒感染的CD 8 T细胞变得功能失调,这种状态称为“衰竭”。mRNA的转录谱揭示了对T细胞耗竭生物学的重要见解,包括鉴定关键转录因子以及免疫调节途径,如PD-1和LAG-3,它们在控制T细胞耗竭中起主要作用。后一项发现导致了非常有希望的治疗慢性
传染病和癌症。尽管有这些进展,CD 8 T细胞耗竭的分子机制仍然不完全确定。具体来说,我们对T细胞耗竭的基因表达程序的理解迄今为止仅限于编码蛋白质的mRNA。在过去的十年中,非编码RNA,特别是microRNA(miRs)已被确定为细胞发育,分化和功能的关键调节因子。然而,miR在
对感染的免疫性仅仅开始被揭示,具体地说,miR在慢性病毒感染期间调节CD 8 T细胞耗竭中的作用是未知的。我们的初步数据表明,miR-155和其他miR与记忆和耗尽的CD 8 T细胞之间的差异有关,但这些非编码RNA如何调节T细胞耗尽尚不清楚。因此,我们假设特定的miR,包括miR-155,调节功能记忆和耗尽的CD 8 T细胞之间的分化,功能和蛋白质编码基因的转录差异。为了验证这一假设,我们提出:目标1。探讨miR-155在慢性病毒感染中的作用。我们将操纵miR-155表达,以测试该miR如何调节慢性病毒感染期间耗尽的CD 8 T细胞的发育和/或持续性。目标2.鉴定在慢性病毒感染期间调节CD 8 T细胞耗竭的新型miR。我们将测试新的差异表达的miR在调节耗竭和记忆中的作用。基于靶向PD-1和其他抑制性受体调节T细胞耗竭的临床方法对于治疗癌症和慢性感染非常有希望。然而,由于疗效范围为10- 50%,显然需要其他方法和对T细胞耗竭的更深入了解。随着调节miR的临床方法的快速发展,拟议的研究将为未来基于miR的感染和癌症治疗进展提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E. John Wherry其他文献
Preferential Loss of Peripheral Non-Naïve CD4+ Lymphocytes in Pediatric Sepsis
- DOI:
10.1016/j.jaci.2020.12.010 - 发表时间:
2021-02-01 - 期刊:
- 影响因子:
- 作者:
Robert Lindell;E. John Wherry;Scott Weiss;Sarah Henrickson - 通讯作者:
Sarah Henrickson
Tu1897 - Human Norovirus-Specific T Cell Responses
- DOI:
10.1016/s0016-5085(17)33394-2 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Vesselin Tomov;Olesya Palko;Chi W. Lau;Meenakshi Bewtra;E. John Wherry - 通讯作者:
E. John Wherry
Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy
针对接受 B 细胞耗竭疗法的多发性硬化症患者,对 COVID-19 疫苗具有持久的 T 细胞免疫力
- DOI:
10.1038/s41541-025-01151-8 - 发表时间:
2025-05-17 - 期刊:
- 影响因子:6.500
- 作者:
Julia Davis-Porada;Ceren Tozlu;Claudia Aiello;Sokratis A. Apostolidis;Amit Bar-Or;Riley Bove;Diego A. Espinoza;Sugeidy Ferreira Brito;Dina Jacobs;Mihir Kakara;Kaho Onomichi;Adelle Ricci;Joseph J. Sabatino;Elizabeth Walker;E. John Wherry;Lili Zhang;Wen Zhu;Zongqi Xia;Philip De Jager;Sarah Flanagan Wesley;Rebecca Straus Farber;Donna L. Farber - 通讯作者:
Donna L. Farber
CD8sup+/sup T cells in the cancer-immunity cycle
癌症免疫循环中的 CD8 阳性 T 细胞
- DOI:
10.1016/j.immuni.2023.09.005 - 发表时间:
2023-10-10 - 期刊:
- 影响因子:26.300
- 作者:
Josephine R. Giles;Anna-Maria Globig;Susan M. Kaech;E. John Wherry - 通讯作者:
E. John Wherry
The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8sup+/sup T cells
SWI/SNF 染色质重塑复合物 BAF 和 PBAF 差异调节耗竭 CD8+T 细胞中的表观遗传转变
- DOI:
10.1016/j.immuni.2023.05.008 - 发表时间:
2023-06-13 - 期刊:
- 影响因子:26.300
- 作者:
Amy E. Baxter;Hua Huang;Josephine R. Giles;Zeyu Chen;Jennifer E. Wu;Sydney Drury;Katherine Dalton;Simone L. Park;Leonel Torres;Brandon W. Simone;Max Klapholz;Shin Foong Ngiow;Elizabeth Freilich;Sasikanth Manne;Victor Alcalde;Viktoriya Ekshyyan;Shelley L. Berger;Junwei Shi;Martha S. Jordan;E. John Wherry - 通讯作者:
E. John Wherry
E. John Wherry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E. John Wherry', 18)}}的其他基金
Engineering HIV-specific T cells that have improved function and persistence
改造 HIV 特异性 T 细胞,改善其功能和持久性
- 批准号:
9891735 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Engineering HIV-specific T cells that have improved function and persistence
改造 HIV 特异性 T 细胞,改善其功能和持久性
- 批准号:
10617349 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox
Tox 对耗竭 CD8 T 细胞的分化和表观遗传学的时间控制
- 批准号:
10685264 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox
Tox 对耗竭 CD8 T 细胞的分化和表观遗传学的时间控制
- 批准号:
10096485 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Engineering HIV-specific T cells that have improved function and persistence
改造 HIV 特异性 T 细胞,改善其功能和持久性
- 批准号:
10450648 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox
Tox 对耗竭 CD8 T 细胞的分化和表观遗传学的时间控制
- 批准号:
10267763 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox
Tox 对耗竭 CD8 T 细胞的分化和表观遗传学的时间控制
- 批准号:
10462695 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Engineering HIV-specific T cells that have improved function and persistence
改造 HIV 特异性 T 细胞,改善其功能和持久性
- 批准号:
10165494 - 财政年份:2020
- 资助金额:
$ 24万 - 项目类别:
Project 3: Genetic and epigenetic basis of resistance to RT and ICB
项目3:RT和ICB抗性的遗传和表观遗传基础
- 批准号:
10360425 - 财政年份:2017
- 资助金额:
$ 24万 - 项目类别:
Project 3: Genetic and epigenetic basis of resistance to RT and ICB
项目3:RT和ICB抗性的遗传和表观遗传基础
- 批准号:
10005192 - 财政年份:2017
- 资助金额:
$ 24万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 24万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 24万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 24万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 24万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 24万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 24万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 24万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 24万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 24万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 24万 - 项目类别: